(Q35981990)

11 August 2017

Enhancement of chemotherapy and nitroimidazole-induced chemopotentiation by the vasoactive agent hydralazine (English)

1 reference

11 August 2017

D W Siemann

1

1 reference

PMC publication ID

1971466

11 August 2017

language of work or name

English

0 references

publication date

1 September 1990

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

62

1 reference

11 August 2017

3

1 reference

11 August 2017

348-353

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1990.295

11 August 2017

0 references

cites work

Potentiation of chemotherapy by hypoxic cell radiation sensitizers--a review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971466

The mechanisms of cytotoxicity and chemosensitization by misonidazole and other nitroimidazoles.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971466

Modification of chemotherapy by nitroimidazoles

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971466

SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971466

Hypoxia in tumors: a paradigm for the approach to biochemical and physiologic heterogeneity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971466

Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazine

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971466

Hypoxia-mediated nitro-heterocyclic drugs in the radio- and chemotherapy of cancer. An overview

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971466

Definitive evidence for hypoxic cells influencing cure in cancer therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971466

Misonidazole reduces blood flow in two experimental murine tumours

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971466

Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971466

A new mouse tumor model system (RIF-1) for comparison of end-point studies

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971466

The role of mitomycin antibiotics in the chemotherapy of solid tumors

24 September 2018

1 reference

12 December 2020

Blood flow and oxygenation of tumors in mice. II. Effects of vasodilator drugs

1 reference

12 December 2020

Potentiation of the tumor cytotoxicity of melphalan by vasodilating drugs

1 reference

12 December 2020

Factors influencing the quantitative estimation of the in vivo survival of cells from solid tumors

1 reference

12 December 2020

In vivo tumor response to single and multiple exposures of adriamycin

1 reference

12 December 2020

Enhancement of chemotherapy agents

1 reference

12 December 2020

Influence of hypoxia and an acidic environment on the metabolism and viability of cultured cells: potential implications for cell death in tumors

1 reference

12 December 2020

The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: evidence for therapeutic gain

1 reference

12 December 2020

Potentiation of combination chemotherapy by nitroheterocyclics

1 reference

12 December 2020

Postirradiation Modification of Tumor Blood Flow: A Method to Increase the Effectiveness of Chemical Radiosensitizers

1 reference

12 December 2020

Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo

1 reference

12 December 2020

An in vitro assay to measure the viability of KHT tumor cells not previously exposed to culture conditions

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1990.295

1 reference

11 August 2017

1 reference

PMC publication ID

1971466

11 August 2017

PubMed publication ID

2206941

1 reference

PMC publication ID

1971466